The lung disease known as idiopathic pulmonary fibrosis (IPF), causes inflammation and scarring (fibrosis) in the lungs which hinders a person's ability to process oxygen often causing shortness
Developed by BioNumerik, Tavocept is a chemotherapeutic agent with uses in oncology and other disease indications. The initial development focus for Tavocept was to prevent peripheral nerve damage,
The study is being conducted by researchers at Johns Hopkins University. Mitomycin-C is a member of an important class of DNA damaging agents used to treat cancer. The
The study will include a total of 36 patients with advanced squamous cell carcinoma of the head and neck. The objective of the study is to investigate the
The vaccine is administered using Inovio Biomedical’s technology called the MedPulser gene delivery system. The research showed that in comparison with the gene gun delivery the MedPulser gene
The original decision to uphold the patent was on August 2 and specifically deals with the active ingredient in Lipitor called atorvastatin. Pfizer’s paatent is due to expire
Novartis had submitted an application in February for the extension of the marketing authorization to include the treatment of the rare disease mastocytosis. Mastocytosis is a disease in
Noxafil is an antifungal agent discovered and developed by Schering-Plough Research Institute to treat this fungal infection also known as oropharyngeal candidiasis (OPC). This follows the FDA approval
Betaseron is indicated for the treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations. Betaseron is the only high-dose, high-frequency interferon beta
In the study 60% of patients treated with Amitiza experienced a spontaneous bowel movement within 24 hours of treatment, and 80% experienced a spontaneous bowel movement within 48
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.